Dilution screener
Every company we cover, scored for dilution risk from its SEC filings. Browse all tickers A to Z
 Palladyne AI Corp. | $3.27 | $161.8M | Pro | Pro |
 West Enclave Merger Corp. | $10.02 | $160.82M | Pro | Pro |
 ALX Oncology Holdings Inc. | $1.30 | $160.53M | Pro | Pro |
 AleAnna, Inc. | $2.39 | $160.44M | Pro | Pro |
 LaFayette Acquisition Corp. Ordinary Share | $10.21 | $160.43M | Pro | Pro |
 Valens Semiconductor Ltd. | $1.48 | $160.25M | Pro | Pro |
 Future Money Acquisition Corp | $10.15 | $160.17M | Pro | Pro |
 Vuzix Corp. | $1.89 | $159.96M | Pro | Pro |
 Adagene Inc. American Depositary Shares | $2.39 | $159.8M | Pro | Pro |
 PDS Biotechnology Corporation | $1.52 | $159.61M | Pro | Pro |
 BayFirst Financial Corp. | $5.90 | $159.08M | Pro | Pro |
 Mayfair Gold Corp. | $2.33 | $158.78M | Pro | Pro |
 Sutro Biopharma, Inc. | $9.59 | $158.7M | Pro | Pro |
 TON Strategy Co. | $2.85 | $158.55M | Pro | Pro |
 Amplify Energy Corp. | $3.81 | $158.16M | Pro | Pro |
 Neostellar Capital Corp. | $5.96 | $157.65M | Pro | Pro |
 Yarrow Bioscience Inc | $16.81 | $157.43M | Pro | Pro |
 Ampco-Pittsburgh Corp. | $7.58 | $157.42M | Pro | Pro |
 Canton Strategic Holdings Inc | $1.96 | $156.97M | Pro | Pro |
 Playboy, Inc. | $1.34 | $156.85M | Pro | Pro |
 Amaero Inc. CDI | $5.47 | $156.68M | Pro | Pro |
 eGain Corporation | $5.95 | $155.66M | Pro | Pro |
 AN2 Therapeutics, Inc. | $4.13 | $155.47M | Pro | Pro |
 QuickLogic Corporation | $8.38 | $155.14M | Pro | Pro |
 GoldMining Inc. | $0.7175 | $154.74M | Pro | Pro |
 The Metals Royalty Company Inc. | $2.28 | $153.7M | Pro | Pro |
 Mammoth Energy Services, Inc. | $3.19 | $153.53M | Pro | Pro |
 Sangoma Technologies Corporation | $4.55 | $152.44M | Pro | Pro |
 Brilliant Earth Group, Inc. | $1.51 | $151.99M | Pro | Pro |
 CuriosityStream Inc. | $2.54 | $150.72M | Pro | Pro |
 BRC Group Holdings, Inc. | $3.72 | $150.15M | Pro | Pro |
 Toro Corp. Common Stock | $4.34 | $149.99M | Pro | Pro |
 Alpha Technology Group Limited Class A Ordinary Shares | $9.10 | $149.96M | Pro | Pro |
 SkyAI, Inc. | $2.93 | $149.51M | Pro | Pro |
 Innate Pharma S.A. ADS | $1.34 | $149.5M | Pro | Pro |
 Commercial Vehicle Group, Inc. | $3.62 | $149.45M | Pro | Pro |
 MacroGenics, Inc. | $2.33 | $149.17M | Pro | Pro |
 Veraxa Biotech AG Ordinary Shares | $0.99 | $148.46M | Pro | Pro |
 UTime Limited Class A Ordinary Shares | $5.56 | $148.2M | Pro | Pro |
 Evolution Petroleum Corporation | $3.63 | $147.54M | Pro | Pro |
 Southern Cross Acquisition I Corp. | $9.97 | $146.85M | Pro | Pro |
 Enigmatig Limited | $5.24 | $146.75M | Pro | Pro |
 GSI Technology, Inc. | $3.80 | $146.25M | Pro | Pro |
 Maywood Acquisition Corp. 2 Class A Ordinary Share | $10.06 | $146.18M | Pro | Pro |
 MaxCyte, Inc. | $1.41 | $146.04M | Pro | Pro |
 National CineMedia, Inc. | $1.55 | $145.62M | Pro | Pro |
 Zapata Quantum, Inc. | $0.75 | $145.34M | Pro | Pro |
 ZenaTech, Inc. | $0.7204 | $145.14M | Pro | Pro |
 Tribeca Strategic Acquisition Corp. | $9.90 | $144.64M | Pro | Pro |
 Protara Therapeutics, Inc. | $2.45 | $143.9M | Pro | Pro |
251-300 of 1,865 companies
Rank every covered company by dilution risk, potential new shares and cash runway with Signal8 Pro.
Unlock with Pro · $59/mo$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)